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Inducible clindamycin resistance due to expression of erm genes in Staphylococcus
aureus: Report from a Tertiary Care Hospital Karachi, Pakistan
Naima Fasih, Seema Irfan, Afia Zafar, Erum Khan, Rumina Hasan
Department of Pathology and Microbiology, Aga Khan University Hospital, Karachi, Pakistan.
Abstract
Objective: To assess the frequency of phenotypic expression of inducible resistance of clindamycin due to
expression of erm genes, in clinical isolates of Staphylococcus aureus (S. aureus), by double disk diffusion test
(D-test).
Method: This was a cross sectional study conducted in the clinical laboratory of Aga Khan University Hospital,
Karachi. A total of 2432, non duplicate clinical isolates of S. aureus, consisting of 1562 methicillin sensitive S.
aureus (MSSA) and 870 methicillin resistant S. aureus (MRSA), were selected from February 2007 to January
2008. One hundred and thirty eight isolates of S. aureus were selected based on discordant resistance pattern
(erythromycin resistant and clindamycin sensitive) on Kirby Bauer Disk Diffusion test and phenotypic expression
of inducible resistance was assessed using D-test.
Result: Analysis of 2432 isolates showed that 64% (n=1553) were susceptible to both clindamycin and
erythromycin by disc diffusion method, while 30% (n=741) showed constitutive resistance (in vitro resistance to
both drugs). 6% (n=138) isolates showed clindamycin-erythromycin discordance on disc diffusion (in vitro
sensitive to clindamycin and resistant to erythromycin). Among the discordant isolates 72% (n=99) had inducible
resistance phenotype detected by D-test and of these 85 isolates (62%) were MRSA.
Conclusion: Inducible resistance is common in our clinical isolates; D-test (a simple phenotypic test) should be
performed on all S. aureus isolates showing clindamycin-erythromycin discordance on disc diffusion, to avoid
erroneous reporting resulting in treatment failure (JPMA 60:750; 2010).
Introduction
Staphylococcus aureus (S. aureus) is a common cause
of both community and nosocomial acquired infections.
Infections range from minor skin infections to life threatening
conditions such as endocarditis, pneumonia and septicaemia.
Increasing antimicrobial drug resistance in S. aureus is one of
the major concerns.1 Rate of methicillin resistant S. aureus
(MRSA) has dramatically increased in recent years.1,2 In
Pakistan exact prevalence of MRSA is not known, however it
is a common hospital acquired pathogen and different
hospitals have reported its prevalence to be around 22-39%.3-
5 Traditionally MRSA has been considered a nosocomial
pathogen and vancomycin considered as drug of choice.
However vancomycin usage is associated with considerable
side effects and cost. Moreover overuse of vancomycin has
led to the emergence of staphylococcal strains with reduced
susceptibility to it.6 Also in the past decade MRSA has
emerged as pathogen for community acquired infections
(CA-MRSA) Unlike hospital acquired MRSA, the CA-
MRSA are known to be sensitive to drugs other then
vancomycin, such as, ciprofloxacin, trimethoprim-
sulphamethoxazole and clindamycin (CL).7
CL is a good substitute to treat soft tissue infections by
both MRSA and MSSA infections. Its low cost, fewer severe
side effects, availability of oral and parenteral forms, lack of
need for renal adjustments, good tissue penetration and
ability to directly inhibit toxin production are its advantages.
CL, further more, is a useful choice in cases of penicillin
allergy.8 Again development of resistance especially
inducible resistance is a major barrier in its usage.
CL belongs to the macrolide, lincosamide and
streptogramin (MLS) family that act through inhibition of
protein synthesis. Bacterial resistance to this group may be
expressed through different mechanisms including target site
modification, macrolide efflux pump and enzymatic
antibiotic inactivation.9 Modification of the ribosomal target
is encoded by the erm genes that cause production of
methylase enzymes which reduce binding of the drug to the
rRNA target. This resistance can be either constitutive or
inducible. If the erm genes are consistently expressed,
isolates show in vitro resistance to erythromycin (ER), CL,
and to other members of MLS, known as constitutive
resistance phenotype. In case of inducible resistance, the erm
genes require an inducing agent to express resistance to CL.
ER can act as a strong inducer of methylase synthesis. These
isolates known as inducible resistance phenotype show in
vitro resistance to ER and susceptibility to CL. CL therapy in
this phenotype can lead to clinical failure.10-13 S. aureus can
also develop isolated macrolide resistance based on presence
of an efflux pump, encoded by the msrA gene which leads to
resistance to macrolides and type B streptogramins but not to
lincosamides. These isolates known as MS phenotype also
show in vitro resistance to ER and susceptibility to CL same
as in inducible resistance phenotype, but CL therapy can be
safely given in infections with this phenotype and there is no
risk of clinical failure. Therefore, it is important to
differentiate these two mechanisms of resistance. 
Phenotypic detection of inducible resistance can be
done by double disk diffusion test (D-test). D-test is simple,
reliable, inexpensive and easy to interpret with high
sensitivity and specificity.14 Molecular markers for the erm
genes are available, but they are costly and inconvenient for
everyday use. In a developing country like Pakistan with high
burden of MRSA, where health associated finances is borne
by the patient, alternatives to vancomycin are in need.
Clindamycin is a good option but prevalence of inducible
resistance should be known, as it varies by geographical
location and bacterial species. So the aim of this study was to
assess the frequency of phenotypic expression of inducible
erm gene expression in clinical isolates of S. aureus by D-test.
Material and Methods
This was a cross sectional study conducted in the
clinical laboratory of Aga Khan University Hospital, Karachi
from February 2007 to January 2008. 2432 consecutive
isolates of S. aureus were collected from clinical samples, by
convenient sampling. These comprised of 1562 MSSA and
870 MRSA isolates. Duplicate isolates were excluded.
Sources were wound, pus, tissue, respiratory secretions, bone,
joint fluid, ascitic fluid, pleural fluid and blood.  S. aureus
was identified using conventional methodology (colony
morphology, gram staining, catalase, coagulase test and
DNase test). Oxacillin resistance was detected by taking
cefoxitin as a surrogate marker.
Susceptibility testing of CL (2 µg), ER (15µg) and
cefoxitin (30µg) were performed by Kirby Bauer disk
diffusion method and interpreted according to Clinical
Laboratory Standard Institute (CLSI) break points.15
Interpretation of the diameters of zones of inhibition
was as follows:
ER-S > 23 mm; ER intermediate 14-22 mm; ER- R < 13 mm 
CL-S > 21 mm; CL intermediate 15-20 mm; CL-R < 14 mm
Cefoxitin-S > 22 mm; Cefoxitin-R < 21 mm
138 isolates of S. aureus were selected based on
discordant resistance pattern for ER and CL (E-R or I and
CL-S) on Kirby Bauer Disk Diffusion test. These isolates
were then tested for detection of phenotypic expression of
inducible erm genes, by double disk diffusion test (D-test).
Detection of inducible resistance erm gene
expression:
Phenotypic expression of erm gene activation was
detected by performing D-test using CLSI guideline.15 A 0.5
McFarland equivalent suspension of organisms was
inoculated onto a Mueller - Hinton agar (MHA) plate, the ER
(15µg) disk was placed 15-26 mm (edge to edge) apart from
CL (2 µg) disk on MHA. Plates were analyzed after 18 hours
of incubation at 35°C.  
Principles of D-test: 
When tested in close proximity, ER (inducing agent)
diffuses into the media and induces the erm gene expression.
This effect extends up to the sensitivity zone on one side of
the CL disk leading to a D-shaped zone of inhibition (Figure).
Interpretation of the D-test:
IsolateS showing circular zones of inhibition with
diameter of < 13 mm for ER and > 21 mm for CL were
interpreted as negative for inducible resistance (D-test
negative). Isolates with same inhibitory diameters as above
but a D-shaped zone around the CL, were interpreted as
positive for inducible resistance (D-test positive) (Figure).
Data Management and statistical analysis:
The data was coded and entered into SPSS 16.0
software for statistical analysis. The frequencies of inducible
CL-R in S. aureus, MSSA and MRSA were calculated and
expressed in percentage. 
Result
A total of 2432 S. aureus isolates were analyzed
during the study period, 1562 (64%) were MSSA and 870 (36
%) were MRSA. Of total isolates 1553 (64%) were
susceptible to both clindamycin and erythromycin (CL-S,
ER-S). 741 (30%) strains showed constitutive resistance; in
vitro resistance to both drugs (CL-R, ER-R). The remaining
138 (6%) isolates expressed clindamycin-erythromycin
discordant (CL-S, ER-R) result. 
Among the discordant S. aureus isolates, 99 (72%)
had inducible resistance phenotype and of these 85 (62%)
isolates were MRSA. Frequency of inducible resistance
Vol. 60, No. 9, September 2010 751
phenotypes in ER-CL discordant S. aureus, MRSA and
MSSA is shown in Table. Our results show that the frequency
of inducible resistance amongst MRSA and MSSA was
similar. 
Overall 99 (4%) out of 2432 isolates of S. aureus
included in this study were reported as being resistant to
clindamycin based on D-test finding. Such resistance would
otherwise have been missed on routine Kirby-Bauer disc
diffusion method.
Discussion
The increased frequency of staphylococcal infections
along with augmented problem of antimicrobial resistance
has led to renewed interest in CL usage. The new guidelines
for treatment of skin and soft tissue infections,16 as well as for
diabetic foot infections17 recommend CL as good choice, for
empirical and therapeutic treatment for mild to moderate
infections and a good alternative to penicillin allergic
patients; however, the guidelines also highlight the risk of
therapeutic failure of using CL in inducible resistant
phenotype. In 1969, McGehee et al demonstrated the
development of CL-R in vivo and in vitro in ER-R
staphylococci.18 Other investigators have confirmed the rapid
in vitro conversion of inducible to constitutive resistance in
staphylococcus.19 Till date, no case-control clinical studies
investigating the relationship between inducible resistance
and CL therapy have been published. So clinical efficacy of
CL usage in infections, caused by inducibly resistant
staphylococci, remains unclear. But there have been a number
of reported CL therapy failures in staphylococcus infections
due to inducible resistance phenotype.10-13 Therefore
questioning the safety of CL in ER-R staphylococcus.
Inducible clindamycin resistance by D-test method is
reported in the present study. The phenotypic erm genes
expression in clinical S. aureus isolates yielded at Clinical
Laboratory of Aga Khan University Hospital. Inducible
resistance pattern on disc diffusion was notable in both
MRSA and MSSA isolates, Majority of discordant isolates
showed inducible expression of erm genes by D-test. This
expression was more pronounced in MRSA isolates.
Our findings are consistent with studies published by
other authors. A study conducted in Turkey by Yilmaz G et al
showed 81.8% inducible resistance in ER-R/CL-S S. aureus
isolates with predominance in MRSA.20 Levin et al
conducted a study from Pennsylvania identified inducible
resistance in 54.2% of S. aureus isolates of which 72.2% were
MRSA.11 Similarly, a study from Alabama reported
discordant resistance in 70% of MRSA and 30% MSSA
isolates, inducible resistance was noticeable by D-test in 60%
of these isolates.21 Contrary to our study Schreckenberger et
al from Chicago studied 83 % inducible resistance in
discordant isolates but majority were MSSA.22 A study
conducted at the University of Texas Health Science Center,
demonstrated that 29% of their discordant S. aureus showed
inducible resistance.14 Gadepalli R et al from India showed
21% inducible resistance.23 Another study from Turkey
revealed 24.3% inducible resistance higher incidence 10.2%
in MSSA.24 Lim et al in a Korean hospital found 14.6%
inducible resistance.25 These findings are suggesting that
inducible resistance phenotype varies widely by hospitals and
geographical region and also among MSSA and MRSA. 
Clinical laboratory can easily miss inducible
resistance by using in vitro susceptibility tests such as broth
and agar dilution, and disc diffusion testing, when ER and CL
discs are placed in nonadjacent positions. Accurate results of
antibiotics susceptibility tests are important for appropriate
and effective therapy. This is important to apply D-test on a
routine basis to detect inducible resistance, so CL can be used
effectively in staphylococcal infections. Therefore, CLSI also
recommends this test for clinical microbiology laboratory.
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Table: Frequency of inducible resistance phenotype in ER-CL
discordant S. aureus, MRSA and MSSA.
ER-R,CL-S Inducible resistance
(Discordant Isolate)-n phenotype- % (n)
S. aureus (138) 72% (99)  
MRSA (85) 70% (60)
MSSA (53) 73% (39)
CL; Clindamycin , ER; Erythromycin, S;  Sensitive, R; Resistance, MRSA;
Methicillin resistant S. aureus, MSSA; Methicillin resistant S. aureus.
Figure: Double disk diffusion test. A; posive test showing blunting of zone of
inhibition around CL disk and formation of  D shape. B;  negative test showing no
blunting of zone of inhibition around CL disk. CL; Clindamycin, E; Erythromycin.
Conclusion
High inducible resistance due to erm genes
expression was detectable by D-test in discordant S. aureus
isolates. In view of therapeutic implication, D-test was
found to be a simple effective test that should be performed
on all S. aureus isolates showing clindamycin-erythromycin
discordance on disc diffusion.
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